Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?

The following license files are associated with this item:

This item appears in the following Collection(s)

Attribution 3.0 United States Except where otherwise noted, this item's license is described as Attribution 3.0 United States

Search Repository


My Account

Statistics